EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A theoretical systems chronopharmacology approach for COVID ‐19: Modeling circadian regulation of lung infection and potential precision therapies

Yu-Yao Tseng iD

CPT: Pharmacometrics & Systems Pharmacology · 2025

DOI: 10.1002/psp4.13277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Yu-Yao Tseng. Beteiligte Einrichtung: Department of Food Science, Nutrition, and Nutraceutical Biotechnology, Shih Chien University, Taipei, Taiwan. Hauptthemen laut MEDLINE: COVID-19 Drug Treatment, Antiviral Agents, Circadian Rhythm. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID‐19 pandemic, caused by SARS‐CoV‐2, has underscored the urgent need for innovative therapeutic approaches. Recent studies have revealed a complex interplay between the circadian clock and SARS‐CoV‐2 infection in lung cells, opening new avenues for targeted interventions. This systems pharmacology study investigates this intricate relationship, focusing on the circadian protein BMAL1. BMAL1 plays a dual role in viral dynamics, driving the expression of the viral entry receptor ACE2 while suppressing interferon‐stimulated antiviral genes. Its critical position at the host‐pathogen interface suggests potential as a therapeutic target, albeit requiring a nuanced approach to avoid disrupting essential circadian regulation. To enable precise tuning of potential interventions, we constructed a computational model integrating the lung cellular clock with viral infection components. We validated this model against literature data to establish a platform for drug administration simulation studies using the REV‐ERB agonist SR9009. Our simulations of optimized SR9009 dosing reveal circadian‐based strategies that potentially suppress viral infection while minimizing clock disruption. This quantitative framework offers insights into the viral‐circadian interface, aiming to guide the development of chronotherapy‐based antivirals. More broadly, it underscores the importance of understanding the connections between circadian timing, respiratory viral infections, and therapeutic responses for advancing precision medicine. Such approaches are vital for responding effectively to the rapid spread of coronaviruses like SARS‐CoV‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 Drug TreatmentAntiviral AgentsCircadian RhythmHumansSARS-CoV-2COVID-19Precision MedicineARNTL Transcription FactorsLungCircadian ClocksAngiotensin-Converting Enzyme 2Models, BiologicalComputer SimulationChronopharmacokinetics

Substanzen

Antiviral AgentsARNTL Transcription FactorsBMAL1 protein, humanAngiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • Department of Food Science, Nutrition, and Nutraceutical Biotechnology, Shih Chien University, Taipei, Taiwan.

ORCID-Profile: Yu-Yao Tseng

Zitieren

APA

Tseng, Y. Y. (2025). A theoretical systems chronopharmacology approach for COVID ‐19: Modeling circadian regulation of lung infection and potential precision therapies. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13277

Vancouver

Tseng YY. A theoretical systems chronopharmacology approach for COVID ‐19: Modeling circadian regulation of lung infection and potential precision therapies. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.13277

BibTeX
@article{Tseng2025,
  author = {Tseng, Yu-Yao},
  title = {A theoretical systems chronopharmacology approach for COVID ‐19: Modeling circadian regulation of lung infection and potential precision therapies},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2025},
  doi = {10.1002/psp4.13277}
}
Kostenlos starten →